DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
93. 原発性胆汁性胆管炎
Primary biliary cholangitis
Clinical trials
/
Disease details
臨床試験数
:
282
/
薬物数
:
245
- (
DrugBank
:
56
) /
標的遺伝子数
:
35
-
標的パスウェイ数
:
113
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2012-000145-12-GB
(
EUCTR
)
15/08/2012
04/07/2012
Pilot study of Rituximab for the treatment of fatigue in PBC
Rituximab for the Treatment of Fatigue in Primary Biliary Cirrhosis (PBC) - RITPBC Study
Severe fatigue in Primary Biliary Cirrhosis
MedDRA version: 18.0;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary;System Organ Class: 10019805 - Hepatobiliary disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Severe fatigue in Primary Biliary Cirrhosis
MedDRA version: 18.0;Level: PT;Classification code 10004 ...
Trade Name:
MabThera
®
Product Name:
MabThera
®
INN or Proposed INN:
Rituximab
Other descriptive name: N/A
Trade Name:
MabThera
®
Product Name:
MabThera
®
INN or Proposed INN:
Rituximab
Other descriptive name: N/ ...
The Newcastle upon Tyne Hospitals NHS Foundation Trust
NULL
Not Recruiting
Female: yes
Male: yes
58
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...
United Kingdom